Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 24;24(1):21.
doi: 10.1186/s12944-025-02440-w.

Predictive value of TG/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study

Affiliations

Predictive value of TG/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study

Elisa Russo et al. Lipids Health Dis. .

Abstract

Background: Insulin resistance (IR) and serum uric acid (SUA) are closely interconnected: SUA contributes to adversely affects the insulin signaling pathway and contributes to IR, while IR is a known predictor for the development of hyperuricemia. The triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C) ratio has been proposed as an easily obtainable marker for IR. This research aimed to investigate the interaction between IR and glomerular filtration rate (GFR)-adjusted uricemia (SUA/GFR ratio) in determining CV risk in a large population cohort study.

Methods: Data from 18,694 subjects were analyzed from Uric acid Right foR heArt Healt (URRAH) database. The study evaluated the association between TG/HDL-C ratio and SUA/GFR ratio, as well as their impact on the development of outcomes during the follow-up study period. The primary endpoint was CV mortality.

Results: After a mean follow-up of 124 ± 64 months, 2,665 (14.2%) CV deaths occurred. The incidence of fatal and non-fatal CV events increased in parallel with the increase of TG/HDL-C quintiles. TG/HDL-C ratio showed a positive association with increasing of SUA/GFR ratio, even in non-diabetic patients. Multivariate analysis showed that the TG/HDL-C ratio increases the mortality risk even after adjustment for potential confounding factors. Finally, IR and GFR-adjusted hyperuricemia showed an additive effect on CV mortality.

Conclusions: Both IR and SUA/GFR ratio independently predict CV mortality, regardless of age, gender, BMI, diabetes, hypertension and statin use. The joint effect of the TG/HDL-C ratio and the elevated SUA/GFR ratio was greater than the presence of each single risk factor on CV mortality. This highlights the importance of monitoring these markers to better assess cardiovascular risk.

Keywords: Cardiovascular mortality; Insulin-resistance; Kidney function; TG/HDL-C ratio; Triglycerides; Uric acid.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The URRAH project was performed according to the Declaration of Helsinki for Human Research (41stWorld Medical Assembly, 1990). The processing of the patients’ personal data collected in this study complies with the European Directive on the Privacy of Data. Approval was sought from the Ethical Committee of the coordinating center at the Division of Internal Medicine of the University of Bologna (No. 77/2018/Oss/AOUBo). Informed consent was obtained from all subjects at recruitment. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Kaplan–Meier survival curves for cardiovascular mortality according to TG/HDL-C quintiles adjusted for SUA/GFR ratio, diabetes and body mass index (BMI). Abbreviations: BMI, body mass index; GFR, glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; SUA, serum uric acid
Fig. 2
Fig. 2
Kaplan–Meier survival curves for cardiovascular mortality according to SUA/GFR ratio (above or below the median) and TG/HDL-C quintiles (1°−2°−3° vs 4°−5° quintiles) adjusted for the presence of diabetes and body mass index (BMI). Abbreviations: BMI, body mass index; GFR, glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; SUA, serum uric acid

References

    1. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17:122. 10.1186/s12933-018-0762-4. - PMC - PubMed
    1. Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: does uric acid have a definitive role? Eur J Intern Med. 2022;103:4–12. 10.1016/j.ejim.2022.04.022. - PubMed
    1. Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78(1):51–7. 10.1016/j.jjcc.2020.12.013. - PubMed
    1. Kataria A, Trasande L, Trachtman H. The effects of environmental chemicals on renal function. Nat Rev Nephrol. 2015;11(10):610–25. 10.1038/nrneph.2015.94. - PMC - PubMed
    1. Ambrosio G, Leiro MGC, Lund LH, Coiro S, Cardona A, Filippatos G, Ferrari R, Piepoli MF, Coats AJS, Anker SD, Laroche C, Almenar-Bonet L, Poder P, Valero DB, Frisinghelli A, Maggioni AP. Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: analysis of the ESC-EORP Heart Failure Long-Term (HF LT) registry. Eur J Intern Med. 2021;89:65–75. 10.1016/j.ejim.2021.04.001. - PubMed

LinkOut - more resources